Utility of Circulating Tumor DNA As a Tool to Detect Minimal Residual Disease in Patients with Metastatic Cancer and Durable Response Following Treatment with Immune Checkpoint Inhibitors
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined